Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems
One of the major impediments to drug development is low aqueous solubility and thus poor
bioavailability, which leads to insufficient clinical utility. Around 70–80% of drugs in the …
bioavailability, which leads to insufficient clinical utility. Around 70–80% of drugs in the …
CRISPR-based genome editing as a new therapeutic tool in retinal diseases
SA Rasoulinejad, F Maroufi - Molecular Biotechnology, 2021 - Springer
Retinal diseases are the primary reasons for severe visual defects and irreversible
blindness. Retinal diseases are also inherited and acquired. Both of them are caused by …
blindness. Retinal diseases are also inherited and acquired. Both of them are caused by …
Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer
Breast carcinoma has one of the highest incidence rates (11.7%), with significant clinical
heterogeneity. Although conventional chemotherapy and surgical resection are the current …
heterogeneity. Although conventional chemotherapy and surgical resection are the current …
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
N Mnyandu, SW Limani, P Arbuthnot, MB Maepa - Virology Journal, 2021 - Springer
Despite the five decades having passed since discovery of the hepatitis B virus (HBV),
together with development of an effective anti-HBV vaccine, infection with the virus remains …
together with development of an effective anti-HBV vaccine, infection with the virus remains …
CRISPR technology: Progress and application in retinal medicine
OA Sibeudu, ON Okonkwo - Nigerian Journal of Vitreoretinal …, 2022 - journals.lww.com
CRISPR is the most popular gene-editing technique. It represents an acronym for “clustered
regularly interspaced short palindromic repeats.” In this era of retinal medicine, the frontier of …
regularly interspaced short palindromic repeats.” In this era of retinal medicine, the frontier of …
[PDF][PDF] Advances in designing Adeno-associated viral vectors for development of anti-HBV gene
N Mnyandu, SW Limani, P Arbuthnot, MB Maepa - 2021 - virologyj.biomedcentral.com
Despite the five decades having passed since discovery of the hepatitis B virus (HBV),
together with development of an effective anti-HBV vaccine, infection with the virus remains …
together with development of an effective anti-HBV vaccine, infection with the virus remains …